No Intervention Drug

7 trials

Sponsors

No, Thai Hematology Society, Faculty of Pharmacy, Silpakorn University, Pakchong Nana hospital, Endowment fund ,Faculty Of Medicine , Chiang Mai University

Conditions

Children with thalassemia disease&#44Dabigatran was used to prevent thromboembolism in Thai AF patients but data about the variation of genetics are limited dabigatran genetics therapeutic drug monitoringDiabetic patient Aspirin Primary prevention Cardiovascular disease Diabetic patient Aspirin Primary prevention Cardiovascular diseaseHemophilia patients with factor VIII clotting activity less than five percent activity and no antibody. Hemophilia A&#44Lack of data about entecarvir use for treatment of chronic hepatitis B virus (HBV) infection in Thailand. chronic hepatitis B virus , entecarvirSubject with non&#45the umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post covid -19 vaccination during pregnancy umbilical cord blood level , SARS-CoV-2 antibody, covid -19 vaccination

Phase 1

Efficacy and safety of Aspirin use for primary prevention of cardiovascular disease in diabetic patients

Active, not recruitingTCTR20220804004

Pakchong Nana hospitalDiabetic patient Aspirin Primary prevention Cardiovascular disease Diabetic patient Aspirin Primary prevention Cardiovascular disease

Start: 2021-09-01Target: 560Updated: 2026-08-03

Phase 2

A pilot study of umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post COVID -19 vaccination during pregnancy.

Active, not recruitingTCTR20230125004

Endowment fund ,Faculty Of Medicine , Chiang Mai Universitythe umbilical cord blood level of SARS-CoV-2 antibody in new born of mother post covid -19 vaccination during pregnancy umbilical cord blood level , SARS-CoV-2 antibody, covid -19 vaccination

Start: 2022-08-22Target: 41Updated: 2026-08-03

Phase 3

The safety and efficacy of plasma-derived factor VIII concentrate produced by National Blood Center, Thai Red Cross Society

RecruitingTCTR20170228002

Thai Hematology SocietyHemophilia patients with factor VIII clotting activity less than five percent activity and no antibody. Hemophilia A&#44

Start: 2017-03-13Updated: 2026-08-03

Safety profile of a liquid formulation of deferiprone (GPO-L-ONE) in thalassemia children with transfusion-induced iron overload: pilot study

RecruitingTCTR20170907001

Children with thalassemia disease&#44

Start: 2017-08-16Target: 30Updated: 2026-08-03

Phase 4

Variation of CES1 and ABCB1 gene in patients received dabigatran at Phramongkutklao Hospital

RecruitingTCTR20220211007

Faculty of Pharmacy, Silpakorn UniversityDabigatran was used to prevent thromboembolism in Thai AF patients but data about the variation of genetics are limited dabigatran genetics therapeutic drug monitoring

Start: 2021-05-03Target: 100Updated: 2026-08-03

A Prospective, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of Entecavir in naive Chronic Hepatitis B treatment- Tertiary care center in Thailand.

Active, not recruitingTCTR20250823001

Berlin Pharmaceutical Industry Co.,Ltd.Lack of data about entecarvir use for treatment of chronic hepatitis B virus (HBV) infection in Thailand. chronic hepatitis B virus , entecarvir

Start: 2025-09-01Target: 34Updated: 2026-08-03

Unknown Phase

Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassemics

RecruitingTCTR20160523003

NoSubject with non&#45

Start: 2015-05-18Updated: 2026-08-03

Related Papers

Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia

Acta Haematologica2016-11-1118 citations